KPIs & Operating Metrics(New)

Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Preferred Shares Issued Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding Shares Repurchased

Moderna (MRNA) Shares Issued (2018 - 2026)

Moderna (MRNA) has disclosed Shares Issued for 9 consecutive years, with $19.0 million as the latest value for Q1 2026.

For Q1 2026, Shares Issued rose 533.33% year-over-year to $19.0 million; the TTM value through Mar 2026 reached $51.0 million, down 5.56%, while the annual FY2025 figure was $35.0 million, 46.97% down from the prior year.
Shares Issued hit $19.0 million in Q1 2026 for Moderna, up from $16.0 million in the prior quarter.
Across five years, Shares Issued topped out at $32.0 million in Q2 2024 and bottomed at $2.0 million in Q3 2025.
Average Shares Issued over 5 years is $13.6 million, with a median of $14.0 million recorded in 2025.
Year-over-year, Shares Issued tumbled 80.0% in 2025 and then surged 533.33% in 2026.
Moderna's Shares Issued stood at $25.0 million in 2022, then tumbled by 40.0% to $15.0 million in 2023, then decreased by 26.67% to $11.0 million in 2024, then soared by 45.45% to $16.0 million in 2025, then increased by 18.75% to $19.0 million in 2026.
According to Business Quant data, Shares Issued over the past three periods came in at $19.0 million, $16.0 million, and $2.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.